Randomized Placebo-Controlled Placebo Trial to Determine the Placebo Effect Size

Area of Science:

• Clinical Medicine
• Pain Management
• Medical Research Methodology

Background:

• Placebo treatments are standard controls in randomized controlled trials (RCTs), but the pure placebo effect remains unevaluated.
• No evidence-based placebo therapies exist, and trials specifically designed to isolate the placebo effect have not been conducted.
• Understanding the pure placebo effect is crucial for accurate assessment of active treatments in clinical trials.

Purpose of the Study:

• To quantify the pure placebo effect on chronic pain using a blinded, randomized controlled trial (RCT) design.
• To introduce and evaluate the Inverse Placebo Randomized Controlled Trial (IPRCT) methodology for analyzing placebo effects.

Main Methods:

• A prospective, randomized, placebo-controlled trial was conducted at medical university centers.
• 106 patients with chronic plantar heel pain received either a blinded or unblinded placebo shockwave treatment.
• Pain reduction was measured using Visual Analogue Scale (VAS) and Roles and Maudsley (RMS) scores after 6 weeks.

Main Results:

• No significant baseline differences in pain scores (VAS, RMS) were observed between the blinded and unblinded groups.
• Patients receiving the blinded placebo treatment reported significantly lower heel pain (VAS, RMS) after 6 weeks.
• The change in pain ratings was significantly greater in the blinded placebo group compared to the unblinded group.

Conclusions:

• The study successfully analyzed true placebo effect sizes using the novel Inverse Placebo Randomized Controlled Trial (IPRCT) design.
• IPRCT offers a more appropriate method for evaluating treatment effects compared to traditional RCTs with placebo controls.
• Future research should explore contextual factors influencing placebo effects within IPRCT frameworks.